The BPC-157 Push Patch uses iontophoresis: a clinically recognized delivery method that provides deeper, more stable tissue saturation and 12 full hours of peptide activity
This is precisely why the FDA has not approved BPC-157 for human use, and why honest providers like BlueWater make this distinction clear upfront
Record the drug name (cyanocobalamin), concentration (mcg/mL), volume drawn, route (IM or SQ), injection site, and the administering clinician
That position has no maintenance phase and no taper, and it supersedes the 250750 mcg range and the 812 week courses that circulated earlier
TB-500 is the synthetic variant of the naturally occurring Thymosin Beta-4, found in both human and animal cells
Thats enough to make me go elsewhere Medication is working as expected Do you have any precautions for your product